Recent Advances in Exosomes as Drug Carriers
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 14236
Special Issue Editors
Interests: colloidal inorganic nanomaterials functionalization; lipid- and polymer-based nanosystems; drug delivery nanovectors; multifunctional targeted nanostructures; theranostics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Exosomes are among the EVs that have been the most extensively studied, and are produced by cells exhibiting a variety of functions and targets. They are frequently utilized to transport therapeutic cargo for medical treatments and can be modified to improve their capacity for the distribution of drugs. In this Special Issue, we aim to highlight innovative works concerning the versatile capabilities of these vesicles to be used as natural nanoparticles for personalized medicine in the treatment of various pathologies.
As the Guest Editor of this Special Issue of Pharamaceutics (IF 6.525; https://www.mdpi.com/journal/Pharmaceutics), entitled “Recent Advances in Exosomes as Drug Carriers”, I invite you to submit your valuable contributions, in the form of original research articles and reviews. Research areas may include (but are not limited to) the following:
- Exosome nanoformulation;
- Exosome mimicry;
- Exosomes as diagnostic tools.
I look forward to receiving your contributions.
Dr. Nicoletta Depalo
Dr. Maria Principia Scavo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.